Abstract
Objectives
To evaluate the effectiveness of current treatments for SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) by delineating the therapeutic choices and the outcome of patients in a medical center of China and review of the literature.
Method
An observational study was performed on patients diagnosed as SAPHO syndrome in the Peking University First Hospital from 2009 to 2015. Clinical data including osteoarticular and cutaneous manifestations, laboratory and medical imaging findings, treatments, and outcomes were analyzed retrospectively. A literature detailing the usage of medicines and SAPHO syndrome patient responses to treatment were selected.
Results
Clinical data of 24 patients were analyzed in this study. The mean age was 42.4 ± 15.5 years old at the time of diagnosis. Of a total of 17 patients that received the combination treatments of NSAIDs and DMARDs, 15 of them experienced an improvement in their symptoms. Bisphosphonates were given to 18 patients. Four patients were treated with TNF blockers, and one of them had adalimumab ineffective and then improved by add-on of DMARDs. The mean follow-up period was 2.5 years. Twenty-one patients (87.5%) had a favorable outcome and exhibited improved disease condition in the last follow-up.
Conclusions
The majority of patients with SAPHO syndrome respond well to combination therapy of NSAIDs, DMARDs, and bisphosphonates. TNF blockers are effective in a patient refractory to NSAID and DMARDs. However, in case TNF blockers are ineffective, add-on of DMARDs may be effective. Thus, the proper application of conventional DMARDs is still worth a position in the treatment of SAPHO syndrome.
Key Points •NSAIDs and DMARDs and/or bisphosphonates can alleviate symptoms of the majority of patients with SAPHO syndrome. •TNF blockers are effective in patients who do not respond well to NSIADs and DMARDs. •In case TNF blockers are ineffective, add-on of conventional DMARDs may be effective. |
Similar content being viewed by others
References
Witt M, Meier J, Hammitzsch A, Proft F, Schulze-Koops H, Grunke M (2014) Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. Semin Arthritis Rheum 43(6):745–750. https://doi.org/10.1016/j.semarthrit.2013.10.010
Rohekar G, Inman RD (2006) Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis. Arthritis Rheum 55(4):665–669. https://doi.org/10.1002/art.22087
Dumolard A, Gaudin P, Juvin R, Bost M, Peoc’h M, Phelip X (1999) SAPHO syndrome or psoriatic arthritis? A familial case study. Rheumatology (Oxford, England) 38(5):463–467. https://doi.org/10.1093/rheumatology/38.5.463
Aljuhani F, Tournadre A, Tatar Z, Couderc M, Mathieu S, Malochet-Guinamand S, Soubrier M, Dubost JJ (2015) The SAPHO syndrome: a single-center study of 41 adult patients. J Rheumatol 42(2):329–334. https://doi.org/10.3899/jrheum.140342
Kahn MF, Khan MA (1994) The SAPHO syndrome. Baillieres Clin Rheumatol 8(2):333–362. https://doi.org/10.1016/s0950-3579(94)80022-7
Mateo L, Sanint J, Rodríguez Muguruza S, Martínez Morillo M, Pérez Andrés R, Domenech Puigcerver S (2017) SAPHO syndrome presenting as an osteolytic lesion of the neck. Reumatol Clin 13(1):44–47. https://doi.org/10.1016/j.reuma.2015.11.016
Takigawa T, Tanaka M, Nakahara S, Sugimoto Y, Ozaki T (2008) SAPHO syndrome with rapidly progressing destructive spondylitis: two cases treated surgically. Eur Spine J 2(Suppl 2):S331–S337. https://doi.org/10.1007/s00586-008-0663-4
Rukavina I (2015) SAPHO syndrome: a review. J Child Orthop 9(1):19–27. https://doi.org/10.1007/s11832-014-0627-7
Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, Kahn MF, Meyer O (1999) SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29(3):159–171. https://doi.org/10.1016/s0049-0172(99)80027-4
Earwaker JW, Cotten A (2003) SAPHO: syndrome or concept? Imaging findings. Skelet Radiol 32(6):311–327. https://doi.org/10.1007/s00256-003-0629-x
Ichikawa J, Sato E, Haro H, Ando T, Maekawa S, Hamada Y (2009) Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int 29(6):713–715. https://doi.org/10.1007/s00296-008-0760-z
Sabugo F, Liberman C, Niedmann JP, Soto L, Cuchacovich M (2008) Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin Rheumatol 27(4):533–535. https://doi.org/10.1007/s10067-007-0767-y
Court C, Charlez C, Molina V, Clerc D, Miquel A, Nordin JY (2005) Isolated thoracic spine lesion: is this the presentation of a SAPHO syndrome? A case report. Eur Spine J 14(7):711–715. https://doi.org/10.1007/s00586-004-0791-4
Skoura E, Giannopoulou C, Zaromytidou E, Pianou N, Houssianakou I (2007) A case of non-malignant multifocal lesions on the methyl diphosphonate technetium-99m bone scan with enteropathy. SAPHO syndrome. Hellenic J Nucl Med 10(1):26–28
Galadari H, Bishop AG, Venna SS, Sultan E, Do D, Zeltser R (2009) Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate. J Am Acad Dermatol 61(1):123–125. https://doi.org/10.1016/j.jaad.2008.10.046
Soyfoo MS, Gangji V, Margaux J (2010) Successful treatment of SAPHO syndrome with ibandronate. J Clin Rheumatol 16(5):253. https://doi.org/10.1097/RHU.0b013e3181e9be89
Just A, Adams S, Brinkmeier T, Barsegian V, Lorenzen J, Schilling F, Frosch P (2008) Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates. Journal der Deutschen Dermatologischen Gesellschaft 6(8):657–660. https://doi.org/10.1111/j.1610-0387.2008.06588.x
Spyridonidis T, Giannakenas C, Papandrianos N, Barla P, Apostolopoulos DJ (2007) Two cases of synovitis, acne, pustulosis, osteitis--SAPHO syndrome. Hellenic J Nucl Med 10(2):109–112
Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A (2004) SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford, England) 43(5):658–661. https://doi.org/10.1093/rheumatology/keh149
Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM (2002) Treatment of SAPHO with pamidronate. Rheumatology (Oxford, England) 41(10):1196–1198. https://doi.org/10.1093/rheumatology/41.10.1196
Zwaenepoel T, Vlam K (2016) SAPHO: treatment options including bisphosphonates. Semin Arthritis Rheum 46(2):168–173. https://doi.org/10.1016/j.semarthrit.2016.04.004
Susanto CR, Nanayakkara PW (2003) The skin is the clue. Eur J Intern Med 14(8):493–494. https://doi.org/10.1016/j.ejim.2003.08.005
Wagner AD, Andresen J, Jendro MC, Hülsemann JL, Zeidler H (2002) Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 46(7):1965–1968. https://doi.org/10.1002/art.10539
Kim CH, Kadhim S, Julien C (2014) Treatment of pain in SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. PM & R 6(1):92–95. https://doi.org/10.1016/j.pmrj.2013.08.610
Ben Abdelghani K, Dran DG, Gottenberg JE, Morel J, Sibilia J, Combe B (2010) Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 37(8):1699–1704. https://doi.org/10.3899/jrheum.091086
Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61(6):813–821. https://doi.org/10.1002/art.24540
Kamata Y, Minota S (2015) Successful treatment of a patient with SAPHO syndrome with certolizumab pegol. Rheumatol Int 35(9):1607–1608. https://doi.org/10.1007/s00296-015-3263-8
Pottecher P, Loffroy R, Estivalet L, Thouant P, Ornetti P, Ricolfi F, Krausé D (2014) SAPHO syndrome revealed by sclerosing mandibular osteomyelitis. Diagn Intervent Imaging 95(9):885–887. https://doi.org/10.1016/j.diii.2014.02.004
Ornetti P, Pottecher P (2014) Clinical images: refractory SAPHO syndrome involving the mandible. Arthritis Rheumatol (Hoboken, NJ) 66(7):1966. https://doi.org/10.1002/art.38632
Marí A, Morla A, Melero M, Schiavone R, Rodríguez J (2014) Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review. J Craniomaxillofac Surg 42(8):1990–1996. https://doi.org/10.1016/j.jcms.2014.09.004
Arias-Santiago S, Sanchez-Cano D, Callejas-Rubio JL, Fernández-Pugnaire MA, Ortego-Centeno N (2010) Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol 90(3):301–302. https://doi.org/10.2340/00015555-0822
Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA (2010) Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford, England) 49(8):1505–1512. https://doi.org/10.1093/rheumatology/keq122
Rosero A, Ruano R, Martin M, Hidalgo C, Garcia-Talavera J (2013) Acute venous thrombosis as complication and clue to diagnose a SAPHO syndrome case. A case report. Acta Reumatol Port 38(3):203–206
Hayem G (2004) SAPHO syndrome. La Revue du Praticien 54(15):1635–1636
Qiu D, Kao PN (2003) Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R&D 4(1):1–18. https://doi.org/10.2165/00126839-200304010-00001
Li C, Sun X, Cao Y, Xu W, Zhang W, Dong Z (2017) Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment. Medicine 96(47):e8903. https://doi.org/10.1097/md.0000000000008903
Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, Zeidler H, Wagner AD (2009) Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 11(5):R140. https://doi.org/10.1186/ar2812
Eyrich GK, Langenegger T, Bruder E, Sailer HF, Michel BA (2000) Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustolosis, hyperostosis, osteitis (SAPHO) syndrome in two sisters. Int J Oral Maxillofac Surg 29(1):49–53
Li C, Zhao Y, Zuo Y, Zhou Y, Zhang F, Liu S, Zhu Q, Chen J, Zhang W, Xu W, Gu Z, Li L, Li F, Tao W, Cao Y, Sun X, Jing H, Chen H, Zhang S, Dong Z, Liu J, Shi X, Hao W, Qiu G, Zhang W, Wu N, Wu Z (2019) Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. Clin Exp Rheumatol 37(4):663–669
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 94 kb)
Rights and permissions
About this article
Cite this article
Huang, H., Zhang, Z., Zhao, J. et al. The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature. Clin Rheumatol 40, 1131–1139 (2021). https://doi.org/10.1007/s10067-020-05322-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05322-x